Want to see AU:AN1 full AI Analyst Report?
AN1 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityThe return to positive operating and net profit marks a meaningful earnings inflection after several loss-making years. If management sustains this improvement, stronger internal earnings can support reinvestment, improve resilience, and establish a more durable base for future growth.
Very Low LeverageVery low leverage reduces interest and refinancing pressure while preserving financial flexibility. A positive, substantial equity base gives Anagenics more capacity to manage operating volatility, fund strategic initiatives, and withstand periods when trading performance or cash generation weakens.
Improved Gross MarginA sharp gross-margin improvement can strengthen the economics of the Hair Again product portfolio and provide greater operating leverage as sales develop. Sustaining better margins would make the recent return to profitability more credible and improve the company’s ability to convert revenue into earnings.
Bears Say
Negative Cash GenerationPersistent negative operating and free cash flow means reported profitability has not yet translated into self-funded operations. Continued cash burn can require use of balance-sheet resources or external capital, limiting strategic flexibility and making the recovery more vulnerable if conditions weaken.
Revenue Below Prior PeakRevenue below the 2024 peak indicates that the earnings recovery is occurring without a clear restoration of the company’s previous sales scale. A smaller revenue base can constrain operating leverage, reduce growth opportunities, and leave profitability more sensitive to changes in product demand.
Unproven Earnings ConsistencyThe long sequence of losses and volatile margins makes the latest profitable period less proven as a durable trend. Until positive earnings are repeated across future reporting periods, investors face uncertainty over whether the improvement reflects a sustainable business reset or a temporary recovery in performance.
Anagenics News
AN1 FAQ
What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$5.91M.
When is Anagenics Limited’s upcoming earnings report date?
Anagenics Limited’s upcoming earnings report date is Mar 03, 2027 which is in 169 days.
How were Anagenics Limited’s earnings last quarter?
Anagenics Limited released its earnings results on Aug 28, 2026. The company reported AU$0 earnings per share for the quarter.
Is Anagenics Limited overvalued?
According to Wall Street analysts Anagenics Limited’s price is currently Overvalued.
Does Anagenics Limited pay dividends?
Anagenics Limited does not currently pay dividends.
What is Anagenics Limited’s EPS estimate?
Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anagenics Limited have?
Anagenics Limited has 985,450,800 shares outstanding.
What happened to Anagenics Limited’s price movement after its last earnings report?
Anagenics Limited reported an EPS of AU$0 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Anagenics Limited?
Currently, no hedge funds are holding shares in AU:AN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Anagenics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.73%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Anagenics Limited
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
EVE Health Group Limited
―
Skin Elements Limited
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Hydration Pharmaceuticals Co. Ltd.
―